Skip to main content
FinSpry Logo
FinSpry
LUCD logo
LUCD
(NASDAQ)
Lucid Diagnostics Inc.
$0.95-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lucid Diagnostics (LUCD) Stock Price & Financial Analysis

Lucid Diagnostics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.92 - $0.97
52-Week High$1.63
52-Week Low$0.90
Open$0.93
Volume777.57K
Average Volume (3M)1.88M
Market Cap96.34M
Shares Outstanding101.95M
Price to Sales (P/S)20.16
Price to Book (P/B)25.87
EV/EBITDA-2.32
Revenue (TTM)5.13M
Net Income (TTM)-45.01M
Free Cash Flow (TTM)-46.44M
EPS (TTM)$-0.38
Profit Margin-876.72%
Operating Margin-959.64%
Return on Equity (ROE)-1125.28%
Debt to Equity6.70
50-Day MA$1.02
200-Day MA$1.15
52-Week Change-10.96%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lucid Diagnostics

What is the current stock price for LUCD?

As of the latest trading session, LUCD stock trades at $0.95. The 52-week range is $0.90–$1.63, with a day range of $0.92–$0.97.

What is the P/E ratio for LUCD?

The P/E ratio (Price-to-Earnings) for LUCD is shown in the Key Statistics section. This valuation metric helps compare Lucid Diagnostics Inc. to industry peers.

Does LUCD pay dividends?

Lucid Diagnostics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LUCD?

Based on 5 analysts, the consensus for LUCD is Buy.

What is the market cap of LUCD?

Lucid Diagnostics's market capitalization is $96.4M, classifying it as a micro-cap company. Lucid Diagnostics operates in the Healthcare sector within the Medical Devices industry.